Hanger Ventures Announces Inaugural Investment
2024年7月19日 - 3:00AM
ビジネスワイヤ(英語)
Hanger Ventures, a Hanger, Inc. business whose primary objective
is to advance orthotics and prosthetics innovation and improve
patient outcomes, today announced its debut investment in Bionic
Power, a Canadian-based firm. A developer of active lower body
smart orthotic devices that enhance personal mobility, Bionic Power
is raising Series A Round funding, with Hanger Ventures committing
as the lead investor.
“We are thrilled to make our inaugural investment in Bionic
Power,” shared James Campbell, Ph.D., Hanger Ventures President and
Hanger, Inc. Chief Clinical Officer. “We look forward to
contributing clinical research, along with technical and commercial
expertise, to bring innovative solutions to the market that have
the potential to meet an unmet clinical need and improve the
quality of life for individuals with mobility challenges.”
Bionic Power devices enhance walking abilities for children and
adults with neuromuscular diseases and conditions, including
cerebral palsy, spina bifida, and stroke. The collaboration
provides Bionic Power with financial funding and services for
product development, clinical trials, and go-to-market support.
“When we learned about the creation of Hanger Ventures, we felt
the opportunity was a great match for Bionic Power’s needs, and the
subsequent discussions confirmed our initial impression,” shared
Gualtiero Guadagni, Ph.D., Bionic Power Chief Executive Officer.
“Hanger Ventures is offering far more than capital, and we are
eager to leverage their support to expand our business and have a
greater impact on those who can benefit from our life-changing
products.”
For more information on Bionic Power, visit
www.bionic-power.com.
About Hanger Ventures – Hanger Ventures invests in
entrepreneurs and small businesses that ignite clinical and
technical advances in orthotics and prosthetics, and is part of the
Hanger, Inc. ecosystem of diversified companies. Hanger Ventures is
focused on accelerating innovation, developing technology, and
improving patient outcomes worldwide. For more information, visit
www.hanger.com/ventures.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240718915859/en/
Krisita Burket, Hanger, Inc. 904-239-4627,
kburket@hanger.com